Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fresenius HemoCare is a global leader in blood technology and transfusion medicine, operating as a specialized division within Fresenius Kabi. The company develops and manufactures advanced systems for blood collection, processing, and cell therapy, including automated apheresis machines and blood component filters. Its flagship products, such as the Amicus and Alyx systems, are widely used in blood centers and hospitals to optimize the collection of platelets, plasma, and red blood cells. Beyond traditional transfusion, the company provides critical infrastructure for the burgeoning cell and gene therapy market through its cell separation and processing technologies. The division's portfolio also includes a variety of blood bags, filters, and storage solutions designed to ensure the safety and quality of blood components.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fresenius HemoCare.